MedTrace Logo

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

NCT00946504 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-03-28

No results posted yet for this study

Summary

To demonstrate the relative bioequivalency comparing Geneva's 10 mg Glipizide tablets to Roerig's 10 mg Glucotrol tablets.

Conditions

Interventions

DRUG

Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)

DRUG

Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)

Sponsors & Collaborators

Principal Investigators

  • Roger D. Anderson, M.D. · Biodecision, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1992-10-31
Primary Completion
1992-10-31
Completion
1992-10-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946504 on ClinicalTrials.gov